Total Payments
$5,693
2024 Payments
$311.10
Companies
52
Transactions
306
Medicare Patients
1,814
Medicare Billing
$229,685
Payment Breakdown by Category
Food & Beverage$5,139 (90.3%)
Education$553.83 (9.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,139 | 298 | 90.3% |
| Education | $553.83 | 8 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $439.73 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $432.05 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $408.74 | 21 | $0 (2024) |
| Amgen Inc. | $373.88 | 14 | $0 (2023) |
| Seagen Inc. | $322.67 | 15 | $0 (2023) |
| Daiichi Sankyo Inc. | $266.07 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $236.93 | 17 | $0 (2024) |
| PFIZER INC. | $221.15 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $206.59 | 12 | $0 (2023) |
| Incyte Corporation | $203.71 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $311.10 | 13 | Daiichi Sankyo Inc. ($96.73) |
| 2023 | $2,000 | 102 | Seagen Inc. ($187.38) |
| 2022 | $2,106 | 112 | Amgen Inc. ($269.40) |
| 2021 | $909.62 | 56 | Novartis Pharmaceuticals Corporation ($81.96) |
| 2020 | $230.53 | 14 | PFIZER INC. ($68.80) |
| 2019 | $135.59 | 9 | Merck Sharp & Dohme Corporation ($25.43) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 07/29/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $79.00 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ONCOLOGY | ||||||
| 01/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: Hematology | ||||||
| 12/21/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Oncology | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: Hematology/Oncology | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 09/08/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: Oncology | ||||||
| 09/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 302 | 632 | $132,197 | $49,180 |
| 2022 | 5 | 462 | 898 | $166,105 | $72,179 |
| 2021 | 8 | 498 | 914 | $135,049 | $65,683 |
| 2020 | 9 | 552 | 812 | $130,250 | $42,643 |
Total Patients
1,814
Total Services
3,256
Medicare Billing
$229,685
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 421 | $79,990 | $29,845 | 37.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 128 | $35,968 | $13,871 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 43 | $5,547 | $1,990 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,990 | $1,878 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 26 | $4,702 | $1,596 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 201 | 511 | $82,690 | $35,795 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 102 | 214 | $49,186 | $23,038 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 62 | $11,780 | $4,681 | 39.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 31 | 31 | $10,307 | $4,352 | 42.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $5,620 | $2,127 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 47 | $5,164 | $1,889 | 36.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 13 | 13 | $1,358 | $296.33 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 180 | 514 | $77,100 | $38,164 | 49.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 80 | $17,040 | $9,060 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 112 | 153 | $15,300 | $7,537 | 49.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 36 | 36 | $11,700 | $4,807 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 28 | 28 | $6,916 | $2,770 | 40.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 35 | 45 | $4,500 | $2,227 | 49.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 43 | 47 | $2,350 | $1,099 | 46.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Facility | 2021 | 11 | 11 | $143.00 | $19.20 | 13.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 103 | 196 | $29,400 | $11,961 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 67 | 176 | $36,620 | $10,176 | 27.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 32 | 32 | $12,640 | $4,181 | 33.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $12,560 | $3,735 | 29.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 72 | 91 | $9,100 | $3,581 | 39.3% |
About Dr. Natalie Harper, MD
Dr. Natalie Harper, MD is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1730447814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natalie Harper, MD has received a total of $5,693 in payments from pharmaceutical and medical device companies, with $311.10 received in 2024. These payments were reported across 306 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($5,139).
As a Medicare-enrolled provider, Harper has provided services to 1,814 Medicare beneficiaries, totaling 3,256 services with total Medicare billing of $229,685. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Lexington, KY
- Active Since 04/26/2012
- Last Updated 05/31/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1730447814
Products in Payments
- KEYTRUDA (Biological) $432.05
- LIBTAYO (Biological) $216.82
- ERLEADA (Drug) $205.47
- Lenvima (Drug) $189.44
- OPDIVO (Biological) $183.51
- KISQALI (Drug) $179.32
- LUMAKRAS (Drug) $137.38
- Enhertu (Drug) $133.71
- JAKAFI (Drug) $133.30
- XTANDI (Drug) $119.12
- DARZALEX (Biological) $112.15
- IMBRUVICA (Drug) $109.34
- INJECTAFER (Drug) $109.24
- FOTIVDA (Drug) $107.81
- BRUKINSA (Drug) $96.51
- GILOTRIF (Drug) $94.86
- ADCETRIS (Biological) $91.22
- REBLOZYL (Biological) $90.58
- TUKYSA (Drug) $89.07
- Trodelvy (Drug) $78.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781